Bottom line
GACCX vs SCHD: the short answer
GACCX (The Gabelli Global Rising Income and Dividend Fund) and SCHD (Schwab U.S. Dividend Equity ETF) are both mutual funds.
Updated Nov 19, 2026
GACCX vs SCHD side by side
| GACCX | SCHD | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Innovator | Schwab |
| Category | Dividend & Equity Income | Dividend & Equity Income |
| Expense ratio | — | 0.06% |
| Annual cost per $10k | — | $6 |
| 10-yr cost on $10k (prospectus) | — | $77 |
| Max front load | — | None |
| 12b-1 fee | — | — |
| 1-yr return | — | +11.6% |
| 5-yr return (annualized) | — | +11.0% |
| 10-yr return (annualized) | — | +11.0% |
| Best quarter | — | +17.1% |
| Worst quarter | — | −21.6% |
| Net assets (fund) | $73.1M | $94.9B |
| Number of holdings | 184 | 102 |
| Portfolio turnover | 5% | 3% |
| Returns as of | — | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
GACCX and SCHD share none of their top holdings.
GACCX top 10
- Berkshire Hathaway Inc — 3.07%
- Rolls-royce Holdings Plc — 2.62%
- Sony Group Corp — 2.61%
- Sony Group Corp — 2.54%
- Rogers Communications Inc — 2.33%
- Cnh Industrial Nv — 2.12%
- Mueller Industries Inc — 2.12%
- Millicom International Cellular Sa — 2.11%
- Bank Of New York Mellon Corp (the) — 1.98%
- Nestle' Sa/ag — 1.94%
SCHD top 10
- QUALCOMM Inc — 6.74%
- Texas Instruments Inc — 5.90%
- UnitedHealth Group Inc — 5.09%
- Coca-Cola Co/The — 3.96%
- Merck & Co Inc — 3.86%
- Chevron Corp — 3.83%
- Verizon Communications Inc — 3.65%
- Procter & Gamble Co/The — 3.55%
- ConocoPhillips — 3.51%
- Amgen Inc — 3.47%
FAQ
What is the difference between GACCX and SCHD?
GACCX (The Gabelli Global Rising Income and Dividend Fund) and SCHD (Schwab U.S. Dividend Equity ETF) are both mutual funds.
Should I own both GACCX and SCHD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.